Company Overview
Company Name
Celcuity
Address
Minneapolis, MN, 55446, United States
Website
celcuity.comApprox. Annual Revenue
$22.0M
Employees
120
Established
2011
About Celcuity
Celcuity is a biotechnology company headquartered in Minneapolis, Minnesota, United States. The company focuses on developing targeted therapies for cancer patients by providing insights into oncogenic pathways. Celcuity's lead candidate is gedatolisib, a dual PI3K - mTOR inhibitor, which is being developed to disrupt the oncogenic process and improve outcomes for cancer patients.
Business Profile
Read from the Celcuity website on Oct 14, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 8/10 · Current news and product availability; Clear navigation and investor information
- Footer copyright year
- 2026
- Website by
- 22 Fillmore
Recent changes
What changed on the Celcuity website and Google listing, as detected by Coldlytics on each visit.
Estimated revenue band moved from $<250K to $10M-25M
Estimated headcount moved from 1 to 101-250 employees
Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.
Find companies by what just changed →Biotech & Life Sciences Companies near Minneapolis, MN
- Provationprovationmedical.com
- Hennepin Healthcare Research Institutehhrinstitute.org
- ShiraTronicsshiratronics.com
- Nuvairanuvaira.com
- Bright Researchbrightresearch.com
- DaVita Clinical Researchdavitaclinicalresearch.com
- Cryosacryosa.com
- Stimdia Medicalstimdia.com
- Francis Medicalfrancismedical.com
- 4C Medical Technologies4cmed.com
Frequently Asked Questions about Celcuity
Categories
Technologies Used
%20--%3e%3csvg%20version='1.1'%20id='st_x5F_cc_x5F_app_x5F_RGB.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20240.0004%20234.0004'%20style='enable-background:new%200%200%20240.0004%20234.0004;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:url(%23SVGID_1_);}%20.st1{fill:%23FFFFFF;}%20%3c/style%3e%3clinearGradient%20id='SVGID_1_'%20gradientUnits='userSpaceOnUse'%20x1='119.9997'%20y1='234.0002'%20x2='119.9997'%20y2='0.0002'%3e%3cstop%20offset='0'%20style='stop-color:%23201F21'/%3e%3cstop%20offset='1'%20style='stop-color:%23313131'/%3e%3c/linearGradient%3e%3crect%20x='-0.0003'%20y='0.0002'%20class='st0'%20width='240'%20height='234'/%3e%3cg%3e%3cpath%20class='st1'%20d='M132.24969,97.95853c-5.60328,18.77988-10.28088,36.91208-15.88416,54.63138%20c-3.18081,9.99579-6.66385,19.53729-11.05544,25.59485c-4.84678,6.81497-13.93402,13.32771-24.83743,13.32771%20c-7.72443,0-15.29683-3.63509-15.29683-11.66174c0-4.99789,5.14901-9.69264,9.23837-9.69264%20c2.42339,0,3.63508,1.36282,4.24046,2.42339c3.7862,6.81497,7.42128,10.75229,9.08724,10.75229s3.02878-2.27135,5.7544-12.1151%20l19.82331-73.26013H99.08337c-1.06058-3.18081,0.45427-7.11812,2.27135-7.87554h14.23625%20c2.72562-8.7841,5.92356-17.60862,10.46719-25.63529c6.81497-12.26713,17.7193-21.95976,32.71205-21.95976%20c11.3586,0,16.05333,5.45216,16.05333,12.41917c-0.15111,7.42036-6.66293,11.20656-9.69263,11.20656%20c-2.42247,0-3.63416-1.81709-4.39159-4.39159c-2.57451-9.69263-5.90643-12.57029-7.87555-12.57029%20c-1.9682,0-4.99789,3.63416-8.3289,11.20656c-4.3925,9.54151-7.28729,19.72977-10.01291,29.72464h17.26501%20c1.05966,2.12023,0.15112,6.66385-2.42339,7.87554H132.24969z'/%3e%3c/g%3e%3c/svg%3e)
Social Profiles
Key Decision Makers
Monica Romero Clinical Trial Manager